MedTrace Logo

Exploration of Investigating ICU Mobilisation With Vasoactive Drugs

NCT03869541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-11-11

Study results available
· View outcomes & findings →

Summary

There is a need to know more about the safety of mobilizing intensive care unit (ICU) patients who are receiving vasoactive drugs that support the heart and blood pressure. But before this research can be done, several uncertainties need to be addressed.

To answer these uncertainties, the investigators will ask ICU patients receiving vasoactive drugs to take part in a study in three main stages. Firstly ICU patients will be asked whether they would be happy to take part in a future research trial on the safety of mobilizing patients who are receiving vasoactive drugs. Secondly, data will be collected about the current mobilization on vasoactive drugs that occurs. Finally, the investigators will try to follow up these patients 60 days after they start the study, to carry out some questionnaires and a walking test with the patients. These tests may be used in future research to measure the effect of mobilizing patients on vasoactive drugs.

Conditions

  • Critical Illness

Interventions

OTHER

Mobilization

Physical rehabilitation

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Anthony Gordon, Prof · Imperial College London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-14
Primary Completion
2019-08-09
Completion
2019-08-09

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03869541 on ClinicalTrials.gov